aspartic acid has been researched along with Marfan Syndrome, Type I in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baptista, J; Eason, J; Hamilton, M; Johnson, K; Jones, G; Kanani, F; Osio, D; Suri, M | 1 |
Babcock, D; Francke, U; Gasner, C; Maslen, C | 1 |
2 other study(ies) available for aspartic acid and Marfan Syndrome, Type I
Article | Year |
---|---|
Traboulsi syndrome caused by mutations in ASPH: An autosomal recessive disorder with overlapping features of Marfan syndrome.
Topics: Aspartic Acid; Calcium-Binding Proteins; Child; Craniofacial Abnormalities; Ectopia Lentis; Fibrillin-1; Humans; Iris; Marfan Syndrome; Membrane Proteins; Mixed Function Oxygenases; Muscle Proteins; Mutation; Transcription Factors | 2022 |
A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly.
Topics: Aged; Amino Acid Sequence; Amino Acid Substitution; Aspartic Acid; Epidermal Growth Factor; Exons; Female; Fibrillin-2; Fibrillins; Histidine; Humans; Male; Marfan Syndrome; Microfilament Proteins; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sequence Alignment; Sequence Deletion; Sequence Homology, Amino Acid; Transcription, Genetic | 1998 |